These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 10597262)
41. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice. Ogawa K; Yamada Y; Kishibe K; Ishizaki K; Tokusashi Y Cancer Res; 1999 Apr; 59(8):1830-3. PubMed ID: 10213486 [TBL] [Abstract][Full Text] [Related]
42. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663 [TBL] [Abstract][Full Text] [Related]
43. Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators. Kotsinas A; Evangelou K; Zacharatos P; Kittas C; Gorgoulis VG Am J Pathol; 2002 Nov; 161(5):1619-34. PubMed ID: 12414510 [TBL] [Abstract][Full Text] [Related]
44. PIN1 gene overexpression and beta-catenin gene mutation/expression in hepatocellular carcinoma and their significance. Wang H; Zhang J; Feng W; Zhang S; Liang H; Wang Y; Zheng Q; Li Z J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):54-7. PubMed ID: 17393110 [TBL] [Abstract][Full Text] [Related]
45. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa. Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624 [TBL] [Abstract][Full Text] [Related]
46. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam. Anna CH; Sills RC; Foley JF; Stockton PS; Ton TV; Devereux TR Cancer Res; 2000 Jun; 60(11):2864-8. PubMed ID: 10850429 [TBL] [Abstract][Full Text] [Related]
47. Genetic alterations involving exon 3 of the beta-catenin gene do not play a role in adenocarcinomas of the esophagus. Wijnhoven BP; Nollet F; De Both NJ; Tilanus HW; Dinjens WN Int J Cancer; 2000 May; 86(4):533-7. PubMed ID: 10797268 [TBL] [Abstract][Full Text] [Related]
48. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Woo DK; Kim HS; Lee HS; Kang YH; Yang HK; Kim WH Int J Cancer; 2001 Mar; 95(2):108-13. PubMed ID: 11241321 [TBL] [Abstract][Full Text] [Related]
49. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Yau TO; Chan CY; Chan KL; Lee MF; Wong CM; Fan ST; Ng IO Oncogene; 2005 Feb; 24(9):1607-14. PubMed ID: 15580286 [TBL] [Abstract][Full Text] [Related]
50. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227 [TBL] [Abstract][Full Text] [Related]
51. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Abraham SC; Wu TT; Hruban RH; Lee JH; Yeo CJ; Conlon K; Brennan M; Cameron JL; Klimstra DS Am J Pathol; 2002 Mar; 160(3):953-62. PubMed ID: 11891193 [TBL] [Abstract][Full Text] [Related]
52. Beta-catenin mutations and expression, 249serine p53 tumor suppressor gene mutation, and hepatitis B virus infection in southern African Blacks with hepatocellular carcinoma. Elmileik H; Paterson AC; Kew MC J Surg Oncol; 2005 Sep; 91(4):258-63. PubMed ID: 16121349 [TBL] [Abstract][Full Text] [Related]
54. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation. Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529 [TBL] [Abstract][Full Text] [Related]
55. Absence of mutations in the beta-catenin and adenomatous polyposis coli genes in papillary and follicular thyroid carcinomas. Miyake N; Maeta H; Horie S; Kitamura Y; Nanba E; Kobayashi K; Terada T Pathol Int; 2001 Sep; 51(9):680-5. PubMed ID: 11696170 [TBL] [Abstract][Full Text] [Related]
56. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Takayasu H; Horie H; Hiyama E; Matsunaga T; Hayashi Y; Watanabe Y; Suita S; Kaneko M; Sasaki F; Hashizume K; Ozaki T; Furuuchi K; Tada M; Ohnuma N; Nakagawara A Clin Cancer Res; 2001 Apr; 7(4):901-8. PubMed ID: 11309340 [TBL] [Abstract][Full Text] [Related]